Subscribe to the CIPS Newsletter
- Home
- Blog
Blog
China as #1: Where Might it Lead the World?
- Analysis
- November 11, 2017
It slowly crept up on us. But in a carefully choreographed 19th Party Congress in late October, President Xi Jinping was enthroned before several thousand elite party loyalists as “absolute monarch,” along with a multi-layered, hand-picked collection of respectful barons (not a baroness in sight) to form his new Politburo and its Standing Committee. This
READ MORE
Ottawa Needs to Re-Evaluate the Mission in Iraq
- Analysis
- November 1, 2017
The Canadian government announced last Friday that it is temporarily suspending its mission to train Iraqi and Iraqi Kurdish forces given growing tension between the two sides. Ottawa should take this opportunity to carefully consider its next steps: because of recent trends, the mission in Iraq will fundamentally change. This is primarily because the Islamic State
READ MORE
The Hidden Connection between Obesity, Heart Disease, and Trade
- Analysis
- October 24, 2017
This week, representatives from most of the world’s governments are meeting at a World Health Organization global conference in Uruguay to tackle the global pandemic of non-communicable diseases (NCDs). These NCDs are the chronic diseases — including cancers, cardiovascular diseases, respiratory diseases, and diabetes — that now kill around 40 million people each year. They are responsible for
READ MORE
Women in Political Life Say #MeToo: Here’s How Harassment and Violence Limit Their Political Lives Worldwide
- Analysis
- October 23, 2017
In the wake of the Harvey Weinstein scandal last week, millions of women and men took to social media to speak out against sexual harassment and violence. Facebook alone saw over 12 million posts as more than 4.7 million users around the world shared their experiences and reacted using the phrase “Me too.” In the United
READ MORE
The CIPS Blog is written only by subject-matter experts.
CIPS blogs are protected by the Creative Commons license: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)